Exact Mass: 291.9748984
Exact Mass Matches: 291.9748984
Found 177 metabolites which its exact mass value is equals to given mass value 291.9748984,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Carboxyphosphamide
In contrast to previous adult studies on urinary metabolites, plasma carboxyphosphamide concentrations did not support the existence of polymorphic metabolism. Plasma concentrations of dechlorethylcyclophosphamide and carboxyphosphamide were correlated in individual patients, suggesting that the activity of both aldehyde dehydrogenase and cytochrome P450 enzyme(s) determine carboxyphosphamide production in vivo. (PMID: 7850793) Detoxification of cyclophosphamide is effected, in part, by hepatic class 1 aldehyde dehydrogenase (ALDH-1)-catalyzed oxidation of aldophosphamide, a pivotal aldehyde intermediate, to the nontoxic metabolite, carboxyphosphamide. (PMID: 9394035) A key finding was the detection of a metabolite, most likely carboxyphosphamide, that is formed only by cytosols from cells expressing either class 3 or class 1 ALDH. (PMID: 8662659) D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards
CHLORBROMURON
CONFIDENCE standard compound; INTERNAL_ID 1318; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4514; ORIGINAL_PRECURSOR_SCAN_NO 4511 CONFIDENCE standard compound; INTERNAL_ID 1318; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9195; ORIGINAL_PRECURSOR_SCAN_NO 9192 CONFIDENCE standard compound; INTERNAL_ID 1318; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4480; ORIGINAL_PRECURSOR_SCAN_NO 4476 CONFIDENCE standard compound; INTERNAL_ID 1318; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4517; ORIGINAL_PRECURSOR_SCAN_NO 4513 CONFIDENCE standard compound; INTERNAL_ID 1318; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9173; ORIGINAL_PRECURSOR_SCAN_NO 9171 CONFIDENCE standard compound; INTERNAL_ID 1318; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4488; ORIGINAL_PRECURSOR_SCAN_NO 4485 CONFIDENCE standard compound; INTERNAL_ID 1318; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4500; ORIGINAL_PRECURSOR_SCAN_NO 4496 CONFIDENCE standard compound; INTERNAL_ID 1318; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4513; ORIGINAL_PRECURSOR_SCAN_NO 4508
Carboxyifosfamide
Carboxyifosfamide is a metabolite of ifosfamide. Ifosfamide (also marketed as Mitoxana and Ifex) is a nitrogen mustard alkylating agent used in the treatment of cancer. It is sometimes abbreviated IFO. (Wikipedia) D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards
5-phospho-alpha-D-ribose cyclic-1,2-phosphate
Bis(4-isothiocyanatobutyl) disulfide
Bis(4-isothiocyanatobutyl) disulfide is found in brassicas. Bis(4-isothiocyanatobutyl) disulfide is a constituent of salad rocket (Eruca sativa) Constituent of salad rocket (Eruca sativa). Bis(4-isothiocyanatobutyl) disulfide is found in brassicas.
4-Hydroperoxycyclophosphamide
Brevifolincarboxylic acid
Brevifolincarboxylic acid belongs to isocoumarins and derivatives class of compounds. Those are polycyclic compounds containing an isochromane which bears a ketone at the carbon C1. Brevifolincarboxylic acid is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Brevifolincarboxylic acid can be found in pomegranate, which makes brevifolincarboxylic acid a potential biomarker for the consumption of this food product. Brevifolincarboxylic acid is extracted from Polygonum capitatum[1], has inhibitory effect on the aryl hydrocarbon receptor (AhR)[2]. Brevifolincarboxylic acid is an α-glucosidase inhibitor with an IC50 of 323.46 μM[3]. Brevifolincarboxylic acid is extracted from Polygonum capitatum[1], has inhibitory effect on the aryl hydrocarbon receptor (AhR)[2]. Brevifolincarboxylic acid is an α-glucosidase inhibitor with an IC50 of 323.46 μM[3].
Brevifolincarboxylic acid
Brevifolincarboxylic acid is a natural product found in Melaleuca leucadendra, Euphorbia maculata, and other organisms with data available. Brevifolincarboxylic acid is extracted from Polygonum capitatum[1], has inhibitory effect on the aryl hydrocarbon receptor (AhR)[2]. Brevifolincarboxylic acid is an α-glucosidase inhibitor with an IC50 of 323.46 μM[3]. Brevifolincarboxylic acid is extracted from Polygonum capitatum[1], has inhibitory effect on the aryl hydrocarbon receptor (AhR)[2]. Brevifolincarboxylic acid is an α-glucosidase inhibitor with an IC50 of 323.46 μM[3].
Brevifolincarboxylic
Brevifolincarboxylic acid is a natural product found in Melaleuca leucadendra, Euphorbia maculata, and other organisms with data available. Brevifolincarboxylic acid is extracted from Polygonum capitatum[1], has inhibitory effect on the aryl hydrocarbon receptor (AhR)[2]. Brevifolincarboxylic acid is an α-glucosidase inhibitor with an IC50 of 323.46 μM[3]. Brevifolincarboxylic acid is extracted from Polygonum capitatum[1], has inhibitory effect on the aryl hydrocarbon receptor (AhR)[2]. Brevifolincarboxylic acid is an α-glucosidase inhibitor with an IC50 of 323.46 μM[3].
4-chloro-3,6,8-trihydroxy-1-methylxanthen-9-one
C14H9ClO5 (292.01384939999997)
9H-Xanthen-9-one, 2-chloro-1,3,6-trihydroxy-8-methyl-
C14H9ClO5 (292.01384939999997)
1-Alcohol,Me ester-Aipha-Oxo-5-(1-propynyl)[2,2-bithiophene]-5-acetic acid
2-acetoxy-4-[2,2]bithiophenyl-5-yl-but-3-yn-1-ol|5-(3-acetoxy-4-hydroxy-1-butynyl)-2,2-bithiophene|5-(4-Hydroxy-3-acetoxybutin-1-yl)-bithienyl-2,2
NSC 652287
RITA is an inhibitor of p53-HDM-2 interaction, binds to p53dN, with a Kd of 1.5 nM, and also induces DNA-DNA cross-links.
5-bromo-3-pheny Salicylic Acid
C13H9BrO3 (291.97350240000003)
Butedronic acid
C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor
2-bromo-1-(4-fluorophenyl)-2-phenylethanone
C14H10BrFO (291.98990019999997)
6-(3-bromophenyl)-2-chloropyridine-3-carbonitrile
C12H6BrClN2 (291.94028460000004)
3-BROMO-4-FLUORO-3-METHYLBENZOPHENONE
C14H10BrFO (291.98990019999997)
ethyl 8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate
C11H8ClF3N2O2 (292.02263739999995)
3-CHLORO-5-(4-CHLOROBENZYLSULFINYL)-1,2,4-THIADIAZOLE
5-Bromo-8-ethoxy-4-hydroxy-3-quinolinecarbonitrile
(7-CHLOROTHIAZOLO[5,4-D]PYRIMIDIN-2-YL)-(4-METHOXYPHENYL)AMINE
Methanone, (2,4-dichlorophenyl)[(2R,3S)-3-phenyloxiranyl]-
Dichloro(N,N,N,N-tetramethylethylenediamine)palladium(II)
5-Chloro-3-iodo-6-methyl-1H-pyrrolo[2,3-b]pyridine
1-chloro-4-(2-chloro-1,1,2-trifluoroethyl)sulfonylbenzene
2-Bromo-6-(3-piperidinyloxy)pyridine hydrochloride
2-Bromo-6-(4-piperidinyloxy)pyridine hydrochloride
4-Hydroperoxycyclophosphamide
A phosphorodiamide that is the active metabolite of the nitrogen mustard cyclophosphamide. It has potent antineoplastic and immunosuppressive properties. D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards
4-BROMO-3-FLUORO-4-METHYLBENZOPHENONE
C14H10BrFO (291.98990019999997)
6-CHLORO-1-(PHENYLSULFONYL)-1H-PYRROLO[2,3-B]PYRIDINE
4-chloro-2-iodo-1-Methyl-1H-pyrrolo[2,3-b]pyridine
4-bromo-2-cyclobutyloxy-1-(difluoromethoxy)benzene
2H-1,3,2-Oxazaphosphorin-2-amine,N,3-bis(2-chloroethyl)tetrahydro-4-hydroperoxy-, 2-oxide
1-bromo-4-diethoxyphosphorylbenzene
C10H14BrO3P (291.98638840000007)
Methyl 4-Bromo-2-(methylsulfonyl)benzoate
C9H9BrO4S (291.94048940000005)
1-[(2-Bromophenyl)sulfanyl]-2,4-dimethylbenzene
C14H13BrS (291.99212780000005)
3-BROMO-3-FLUORO-4-METHYLBENZOPHENONE
C14H10BrFO (291.98990019999997)
1H-Pyrrolo[2,3-b]pyridine, 4-chloro-1-(phenylsulfonyl)-
5-bromo-1-(4-fluorophenyl)-phthalide
C14H10BrFO (291.98990019999997)
4,6-DINITRO-1,3-BENZENEDICARBONYL CHLORIDE
C8H2Cl2N2O6 (291.92899320000004)
5-(chloromethyl)-3-[(3,4-dichlorophenoxy)methyl]-1,2,4-oxadiazole
dimethyl 5-chlorosulfonylbenzene-1,3-dicarboxylate
C10H9ClO6S (291.98083640000004)
2-(acetylamino)-5-(aminosulphonyl)-4-chlorobenzoic acid
C9H9ClN2O5S (291.99206940000005)
2-(3-CHLORO-4-FLUOROPHENYL)-4,5-DICHLORO-PYRIDAZINE-3-(2H)-ONE
4-BROMO-4-FLUORO-3-METHYLBENZOPHENONE
C14H10BrFO (291.98990019999997)
5-(chloromethyl)-3-[(2,6-dichlorophenoxy)methyl]-1,2,4-oxadiazole
(4-Bromo-thiazol-2-yl)-Methyl-carbamic acid tert-butyl ester
Gastric Inhibitory Polypeptide (porcine) trifluoroacetate salt
ethyl 6-chloro-2-(trifluoroMethyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylate
C11H8ClF3N2O2 (292.02263739999995)
METHYL 3-BROMO-4-(METHYLSULFONYL)BENZOATE
C9H9BrO4S (291.94048940000005)
Ethyl 2-(5-bromo-2-methylphenyl)-2,2-difluoroacetate
(4,8-dioxothieno[3,2-f][1]benzothiol-2-yl)methyl acetate
7-chloro-4-iodo-3-methyl-1H-pyrrolo[2,3-c]pyridine
3-CHLORO-5-(3-CHLOROBENZYLSULFINYL)-1,2,4-THIADIAZOLE
Ruthenium(2+),pentaamminechloro-, chloride (1:2), (OC-6-22)-
2-Chloro-3,6,8-trihydroxy-1-methyl-9H-xanthen-9-one
C14H9ClO5 (292.01384939999997)
5-(2-thienyl)-4-{[(E)-2-thienylmethylidene]amino}-4H-1,2,4-triazole-3-thiol
Iniparib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor
Perfosfamide
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
Pergamid (TN)
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards
RITA (NSC 652287)
RITA is an inhibitor of p53-HDM-2 interaction, binds to p53dN, with a Kd of 1.5 nM, and also induces DNA-DNA cross-links.
Carboxyphosphamide
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards
Carboxyifosfamide
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards
KRAS inhibitor-9
KRAS inhibitor-9, a potent KRAS inhibitor (Kd=92 μM), blocks the formation of GTP-KRAS and downstream activation of KRAS. KRAS inhibitor-9 binds to KRAS G12D, KRAS G12C and KRAS Q61H protein with a moderate binding affinity. KRAS inhibitor-9 causes G2/M cell cycle arrest and induces apoptosis. KRAS inhibitor-9 selectively inhibits the proliferation of NSCLC cells with KRAS mutation but not normal lung cells[1].